about
Physiological and Pharmacological Roles of FGF21 in Cardiovascular DiseasesBone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsNew Molecular Insights of Insulin in Diabetic CardiomyopathySubclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and PerspectivesInsulin resistance and hyperinsulinaemia in diabetic cardiomyopathyMitochondrial Mechanisms in Septic CardiomyopathyThe mitochondria in diabetic heart failure: from pathogenesis to therapeutic promiseHeart Failure: a Major Cardiovascular Complication of Diabetes MellitusExtracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief ReviewThe Flexibility of Ectopic LipidsDiabetic Cardiomyopathy: Does the Type of Diabetes Matter?Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heartMitochondrial health, the epigenome and healthspanSex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusDiagnostic approaches for diabetic cardiomyopathy.Insulin Signaling and Heart Failure.Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study.Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.Comprehensive metabolic modeling of multiple 13C-isotopomer data sets to study metabolism in perfused working hearts.Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats.Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts.Application of a novel curcumin analog in the management of diabetic cardiomyopathy.Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetesTargeting metabolic disturbance in the diabetic heart.Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome.The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats.Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitusTime course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance.cAMP-dependent Protein Kinase (PKA) Signaling Is Impaired in the Diabetic HeartMetabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet-Induced Metabolic Heart DiseaseMaternal high-fat diet impairs cardiac function in offspring of diabetic pregnancy through metabolic stress and mitochondrial dysfunctionIn vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within miceObestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.
P2860
Q26744232-2482C690-E0DF-45D0-B76D-E2F6EB3DDB5AQ26749552-713D6801-7445-4F06-B6F1-4322AFE4E8BDQ26752678-24275E1C-8FA0-412A-85F2-492A54E0DC5CQ26771750-9183F2E8-C306-49B7-A885-B0558FADC97AQ26775037-CB291688-8619-41DA-AADC-C920F5322D4CQ26801508-BC6D28EB-CC2A-422F-910F-6A411E4D1251Q26829731-728CE7F2-AC58-4F0D-ABB5-C3C1CD33AD27Q28066310-6C46BBC6-77DE-4F6C-AD0F-A29513CA7965Q28073215-1BC22017-41CE-4C8E-83AB-6375ADA5E459Q28076063-744D64F0-AB2C-4C21-842B-B9DEEEF4DF30Q28079593-B9B5097C-BB70-419B-AD20-7DA244136637Q28383474-C387A850-E394-4C44-BF3D-B5994157E5CFQ28391740-B21D753A-FF66-4DDA-A7D9-1075E9B09BFDQ28395801-77995486-689A-49D5-9D71-5AB4C95E770FQ30362092-15EBEF1A-4EDB-4E2A-A3F7-9F38185527ADQ30377910-3027CBE0-6440-468A-95B8-70E6F3AE0516Q30391941-F2BBC78D-DC56-4672-99A3-98FB18CD6C3DQ30396728-1C091F3F-1785-43F5-8CCC-6D7D216EB7F1Q31119881-4F80AE6A-4049-4A50-ADD7-82C6F443057EQ33660548-31EB2D12-C9BF-4BF2-95B5-224508651C3FQ33883650-40B3FF1A-8B3F-41A3-9BF6-2105DDDD3313Q33959744-B6776E72-C454-4802-AAEF-A1C55C819747Q34227841-594326C0-A64C-4395-B4AB-B029993382F5Q34579301-B4331E08-BACC-412F-995C-DF84059D9EF8Q34683091-BB65FB16-51B7-4058-B925-A4AD78FE1902Q34994502-E7A4D203-6B3B-4DA4-8ABB-C76182E9E045Q35084845-CB1ADC5D-ADDC-4701-85FF-F95BD65A58C9Q35667039-87DE4BBA-E67E-4795-93D2-56CF329A675AQ35667311-CABD46DB-D35F-4D92-8AD4-75303C9D2541Q35807000-F4C869F3-6BED-42A5-BC19-28ED2FDFC3E6Q35842699-A2468AAF-89E6-492D-AAF1-E0F350FAA207Q36225147-A9ADD3AF-9A19-47AF-A954-1318E07DA93FQ36234790-EA2B4BF2-0097-4855-95C8-76D5F1FA0851Q36259181-C529964E-2DBE-49A3-B038-A8AAE262EEF2Q36444031-E4936876-6438-4234-8184-D45046B9098BQ36800422-6481401C-0485-4384-AED5-135B62D9E839Q36877638-9C388B89-F5C9-4440-899E-F3A1B357FFB9Q36902365-FE5902BA-BCCA-4382-B6E2-784770BAEA23Q36902956-4ECF1686-8DC8-4E91-8AF9-B3096BDD9657Q37034764-D043B1E9-BA7B-4B3C-B5D5-68DF08951873
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of diabetic cardiomyopathy.
@en
Molecular mechanisms of diabetic cardiomyopathy.
@nl
type
label
Molecular mechanisms of diabetic cardiomyopathy.
@en
Molecular mechanisms of diabetic cardiomyopathy.
@nl
prefLabel
Molecular mechanisms of diabetic cardiomyopathy.
@en
Molecular mechanisms of diabetic cardiomyopathy.
@nl
P2860
P1433
P1476
Molecular mechanisms of diabetic cardiomyopathy
@en
P2093
Heiko Bugger
P2860
P2888
P304
P356
10.1007/S00125-014-3171-6
P50
P577
2014-01-30T00:00:00Z